Literature DB >> 24163752

A review of clinical practice guidelines for lung cancer.

Jutta J von Dincklage1, David Ball, Gerard A Silvestri.   

Abstract

Clinical practice guidelines are important evidence-based resources to guide complex clinical decision making. However, it is challenging for health professionals to keep abreast available guidelines and to know how and where to access relevant guidelines. This review examines currently available guidelines for lung cancer published in the English language. Important key features are listed for each identified guideline. The methodology, approaches to dissemination and implementation, and associated resources are summarised. General challenges in the area of guideline development are highlighted. The potential to collaborate more widely across lung cancer guideline developers by sharing literature searches and assessments is discussed.

Entities:  

Keywords:  Clinical practice guidelines; clinical practice guideline development; evidence-based medicine; lung neoplasms; non-small cell lung carcinoma; small cell lung carcinoma

Year:  2013        PMID: 24163752      PMCID: PMC3804874          DOI: 10.3978/j.issn.2072-1439.2013.07.37

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  31 in total

Review 1.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

Review 2.  The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies.

Authors:  Pablo Alonso-Coello; Affan Irfan; Ivan Solà; Ignasi Gich; Mario Delgado-Noguera; David Rigau; Sera Tort; Xavier Bonfill; Jako Burgers; Holger Schunemann
Journal:  Qual Saf Health Care       Date:  2010-12

3.  Principles of evidence based medicine.

Authors:  A K Akobeng
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

4.  Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive.

Authors:  Roman Jaeschke; Gordon H Guyatt; Phil Dellinger; Holger Schünemann; Mitchell M Levy; Regina Kunz; Susan Norris; Julian Bion
Journal:  BMJ       Date:  2008-07-31

5.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

Authors:  A Brunelli; A Charloux; C T Bolliger; G Rocco; J-P Sculier; G Varela; M Licker; M K Ferguson; C Faivre-Finn; R M Huber; E M Clini; T Win; D De Ruysscher; L Goldman
Journal:  Eur Respir J       Date:  2009-07       Impact factor: 16.671

6.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  S Peters; A A Adjei; C Gridelli; M Reck; K Kerr; E Felip
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

7.  Methodology for development of guidelines for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Sandra Zelman Lewis; Rebecca Diekemper; Doreen J Addrizzo-Harris
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  Introduction to the Third Edition: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  W Michael Alberts
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 9.  First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.

Authors:  John Goffin; Christina Lacchetti; Peter M Ellis; Yee C Ung; William K Evans
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

10.  Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline.

Authors:  George Rodrigues; Gregory M M Videtic; Ranjan Sur; Andrea Bezjak; Jeffrey Bradley; Carol A Hahn; Corey Langer; Keith L Miller; Benjamin J Moeller; Kenneth Rosenzweig; Benjamin Movsas
Journal:  Pract Radiat Oncol       Date:  2011-04-08
View more
  8 in total

1.  Lung cancer.

Authors:  Kwun M Fong
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.

Authors:  Duoguang Wu; Baishen Chen; Fei Cui; Xiaotian He; Wenjian Wang; Minghui Wang
Journal:  Cell Prolif       Date:  2016-06-28       Impact factor: 6.831

Review 3.  Strategies for Translating Evidence-Based Medicine in Lung Cancer into Community Practice.

Authors:  Stephen A Rosenberg; Andrew M Baschnagel; Stephen J Bagley; Nadine Housri
Journal:  Curr Oncol Rep       Date:  2017-01       Impact factor: 5.075

4.  Impact of educational interventions on utilization patterns of anticancer agents in patients with breast cancer at the specialty oncology care setting in South India.

Authors:  Aakanksha Sharma; Himanshu Patel; Gurumurthy Parthasarathi
Journal:  Perspect Clin Res       Date:  2020-12-09

5.  Evaluation of the Efficacy and Safety of the Herbal Formula PM014 in a Cisplatin- and Paclitaxel-Treated Tumor-Bearing Mouse Model.

Authors:  Chanju Lee; Hyunju Jeong; Kwang Hyung Lee; Sehyun Park; Mi Jung Gang; Soo Kyung Bae; Hyunsu Bae
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

Review 6.  Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases.

Authors:  Xue Jin; Ling Song; Chao-Chao Ma; Yan-Chun Zhang; Shui Yu
Journal:  Saudi Pharm J       Date:  2020-11-04       Impact factor: 4.330

7.  Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.

Authors:  Changran Geng; Harald Paganetti; Clemens Grassberger
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

8.  Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP).

Authors:  Clara Salas; Javier Martín-López; Antonio Martínez-Pozo; Teresa Hernández-Iglesias; David Carcedo; Lucia Ruiz de Alda; J Francisco García; Federico Rojo
Journal:  J Clin Pathol       Date:  2021-03-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.